Trial in progress: Multicenter observational study to evaluate the relationship between gut bacterial flora and their therapeutic or adverse effects in advanced non-small cell lung cancer patients treated with nivolumab.

TPS9114Background: Nivolumabis one of the standard therapies for pretreated advanced non-small cell lung cancer (NSCLC). A correlation between PD-L1expression on tumor cells and antitumor effects...